Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
18 19 Search
2022
The pseudogenes of eukaryotic translation elongation factors (EEFs): Role in cancer and other human diseases
Genes & Diseases
2022
Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
Frontiers in Genetics
2021
Aberrant Expression of Long Non-coding RNAs in Exosomes in Follicle Fluid From PCOS Patients
Frontiers in Genetics
2021
Ginsenoside Rh7 Suppresses Proliferation, Migration and Invasion of NSCLC Cells Through Targeting ILF3-AS1 Mediated miR-212/SMAD1 Axis
Frontiers in Oncology
2021
Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer
Cancer Cell International
2021
LncRNA LINC01305 promotes cervical cancer progression through KHSRP and exosome-mediated transfer
Aging
2021
Identification of an Immune-Based mRNA–lncRNA Signature for Overall Survival in Cervical Squamous Cell Carcinoma
Future Oncology
2021
Mechanism underlying long non‑coding RNA ILF3‑AS1‑mediated inhibition of cervical cancer cell proliferation, invasion and migration, and promotion of apoptosis
Molecular Medicine Reports
2020
Identification of a 6‐lncRNA prognostic signature based on microarray re‐annotation in gastric cancer
Cancer Medicine
2020
Roles of long non-coding RNAs in cervical cancer
Life Sciences
2020
Development and validation of a five‐lncRNA signature with prognostic value in colon cancer
Journal of Cellular Biochemistry
2020
Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis
The International Journal of Biological Markers
2020
The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma
DNA and Cell Biology
2020
A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer
Frontiers in Pharmacology
2020
Six-lncRNA Immune Prognostic Signature for Cervical Cancer
Frontiers in Genetics
2020
Prognosis prediction signature of seven immune genes based on HPV status in cervical cancer
International Immunopharmacology
2020
A five‐mRNA signature associated with post‐translational modifications can better predict recurrence and survival in cervical cancer
Journal of Cellular and Molecular Medicine
2020
Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma
Frontiers in Genetics
Additional cited-by details will be shown when available from Crossref